TN2009000529A1 - Methods and compositions for treating allergic diseases - Google Patents
Methods and compositions for treating allergic diseasesInfo
- Publication number
- TN2009000529A1 TN2009000529A1 TNP2009000529A TN2009000529A TN2009000529A1 TN 2009000529 A1 TN2009000529 A1 TN 2009000529A1 TN P2009000529 A TNP2009000529 A TN P2009000529A TN 2009000529 A TN2009000529 A TN 2009000529A TN 2009000529 A1 TN2009000529 A1 TN 2009000529A1
- Authority
- TN
- Tunisia
- Prior art keywords
- methods
- compositions
- allergic diseases
- treating allergic
- antibodies
- Prior art date
Links
- 208000026935 allergic disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 101000956427 Homo sapiens Cytokine receptor-like factor 2 Proteins 0.000 abstract 1
- 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 abstract 1
- 102100031294 Thymic stromal lymphopoietin Human genes 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000011664 signaling Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94520507P | 2007-06-20 | 2007-06-20 | |
| PCT/EP2008/057731 WO2008155365A1 (fr) | 2007-06-20 | 2008-06-18 | Procédés et compositions pour traiter des maladies allergiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2009000529A1 true TN2009000529A1 (en) | 2011-03-31 |
Family
ID=39846944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2009000529A TN2009000529A1 (en) | 2007-06-20 | 2009-12-17 | Methods and compositions for treating allergic diseases |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8101182B2 (fr) |
| EP (1) | EP2170957A1 (fr) |
| JP (1) | JP2010530233A (fr) |
| KR (1) | KR20100034015A (fr) |
| CN (1) | CN102027012A (fr) |
| AR (1) | AR067045A1 (fr) |
| AU (1) | AU2008265128A1 (fr) |
| BR (1) | BRPI0813725A2 (fr) |
| CA (1) | CA2691157A1 (fr) |
| CL (1) | CL2008001826A1 (fr) |
| CO (1) | CO6251325A2 (fr) |
| CR (1) | CR11152A (fr) |
| EA (1) | EA201000006A1 (fr) |
| EC (1) | ECSP099812A (fr) |
| IL (1) | IL202573A0 (fr) |
| PE (1) | PE20090768A1 (fr) |
| TN (1) | TN2009000529A1 (fr) |
| TW (1) | TW200918557A (fr) |
| WO (1) | WO2008155365A1 (fr) |
| ZA (1) | ZA200908711B (fr) |
Families Citing this family (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1129190T4 (en) | 1998-11-13 | 2017-04-03 | Immunex Corp | Human TSLP DNA and polypeptides |
| JP5329016B2 (ja) | 2001-07-23 | 2013-10-30 | イミュネックス・コーポレーション | 修飾したヒト胸腺ストローマ細胞リンホポエチン |
| US8470966B2 (en) | 2007-08-10 | 2013-06-25 | Protelica, Inc. | Universal fibronectin type III binding-domain libraries |
| US8680019B2 (en) * | 2007-08-10 | 2014-03-25 | Protelica, Inc. | Universal fibronectin Type III binding-domain libraries |
| EP2222846B1 (fr) * | 2007-08-10 | 2017-05-03 | Protelix, Inc. | Bibliothèques universelles de domaines de liaison de la fibronectine de type iii |
| US7982016B2 (en) | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| CN101986784A (zh) * | 2008-02-07 | 2011-03-16 | 先灵公司 | 基因工程tslpr抗体 |
| AR082163A1 (es) * | 2010-07-15 | 2012-11-14 | Hoffmann La Roche | Anticuerpos especificamente ligantes del tslpr humano y metodos de utilizacion de los mismos |
| KR101221649B1 (ko) * | 2010-11-01 | 2013-01-14 | 광주과학기술원 | 알러지 질환의 예방 또는 치료용 약제학적 조성물, 그의 스크리닝 방법 |
| TWI635097B (zh) * | 2013-08-09 | 2018-09-11 | 日商安斯泰來製藥股份有限公司 | 新穎抗人類ｔｓｌｐ受體抗體 |
| US10722655B2 (en) | 2014-05-07 | 2020-07-28 | Amgen Inc. | Autoinjector with shock reducing elements |
| MX377275B (es) | 2014-05-16 | 2025-03-07 | Amgen Inc | Ensayo para detectar poblaciones celulares linfocitos t colaboradores 1 (th1) y linfocitos t colaboradores (th2). |
| CN106470716B (zh) | 2014-06-03 | 2020-07-17 | 安姆根有限公司 | 可控制药物递送系统和使用方法 |
| AU2015332557B2 (en) | 2014-10-14 | 2020-05-14 | Amgen Inc. | Drug injection device with visual and audio indicators |
| MA54716A (fr) | 2014-10-23 | 2021-11-17 | Amgen Inc | Réduction de la viscosité de formulations pharmaceutiques |
| EP3233159B1 (fr) | 2014-12-19 | 2020-03-04 | Amgen Inc. | Dispositif d'administration de medicaments avec bouton bouge ou panneau d'interface utilisateur |
| CA3069716C (fr) | 2015-02-17 | 2021-11-09 | Amgen Inc. | Dispositif d'administration de medicament a securisation assistee par depression et/ou retour d'informations |
| EP3981450A1 (fr) | 2015-02-27 | 2022-04-13 | Amgen, Inc | Dispositif d'administration de médicament ayant un mécanisme de protection d'aiguille présentant un seuil réglable de résistance au mouvement de l'élément de protection d'aiguille |
| WO2017039786A1 (fr) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Adaptateur d'ensemble de seringue pour une seringue |
| EP3347377B1 (fr) | 2015-09-09 | 2021-02-17 | Novartis AG | Anticorps de liaison à la lymphopoïétine stromale thymique (tslp) et méthodes d'utilisation des anticorps |
| WO2017042701A1 (fr) | 2015-09-09 | 2017-03-16 | Novartis Ag | Anticorps de liaison à la lymphopoïétine stromale thymique (tslp) et méthodes d'utilisation des anticorps |
| US11351308B2 (en) | 2015-12-09 | 2022-06-07 | Amgen Inc. | Auto-injector with signaling cap |
| CA3008779A1 (fr) | 2015-12-18 | 2017-06-22 | Astellas Pharma Inc. | Composition pharmaceutique contenant un anticorps anti-recepteur de la tslp humaine |
| US11154661B2 (en) | 2016-01-06 | 2021-10-26 | Amgen Inc. | Auto-injector with signaling electronics |
| WO2017160799A1 (fr) | 2016-03-15 | 2017-09-21 | Amgen Inc. | Réduction de la probabilité de casse du verre dans des dispositifs d'administration de médicament |
| US11541168B2 (en) | 2016-04-29 | 2023-01-03 | Amgen Inc. | Drug delivery device with messaging label |
| US11389588B2 (en) | 2016-05-02 | 2022-07-19 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
| JP7309363B2 (ja) | 2016-05-13 | 2023-07-18 | アムジエン・インコーポレーテツド | バイアル・スリーブ組立体 |
| EP3458988B1 (fr) | 2016-05-16 | 2023-10-18 | Amgen Inc. | Chiffrement de données dans des dispositifs médicaux à capacité de calcul limitée |
| WO2017209899A1 (fr) | 2016-06-03 | 2017-12-07 | Amgen Inc. | Appareils et procédés d'essai au choc destinés aux dispositifs d'administration de médicaments |
| US11285266B2 (en) | 2016-07-01 | 2022-03-29 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
| WO2018034784A1 (fr) | 2016-08-17 | 2018-02-22 | Amgen Inc. | Dispositif d'administration de médicament avec détection de positionnement. |
| EP3532127A1 (fr) | 2016-10-25 | 2019-09-04 | Amgen Inc. | Injecteur porté sur le corps |
| CA3049780A1 (fr) | 2017-01-17 | 2018-07-26 | Amgen Inc. | Dispositifs d'injection et procedes d'utilisation et d'assemblage associes |
| MX2019009625A (es) | 2017-02-17 | 2019-10-09 | Amgen Inc | Dispositivo de administracion de farmacos con trayectoria de flujo de fluido esteril y metodo relacionado de ensamblaje. |
| US11369736B2 (en) | 2017-02-17 | 2022-06-28 | Amgen Inc. | Cannula insertion and retraction mechanisms |
| JP2020508803A (ja) | 2017-03-06 | 2020-03-26 | アムジエン・インコーポレーテツド | 作動防止特徴部を備える薬物送達デバイス |
| CA3052482A1 (fr) | 2017-03-07 | 2018-09-13 | Amgen Inc. | Insertion d'aiguille par surpression |
| EP3592404A1 (fr) | 2017-03-09 | 2020-01-15 | Amgen Inc. | Mécanisme d'insertion pour dispositif d'administration de médicament |
| HUE063805T2 (hu) | 2017-03-28 | 2024-01-28 | Amgen Inc | Dugattyúrúd és fecskendõ összeállító rendszer és eljárás |
| WO2018201064A1 (fr) | 2017-04-28 | 2018-11-01 | Amgen Inc. | Dipeptides n-acétylés et non acétylés contenant de l'arginine destinés à réduire la viscosité de compositions visqueuses de polypeptides thérapeutiques |
| CA3061982A1 (fr) | 2017-06-08 | 2018-12-13 | Amgen Inc. | Ensemble de seringue d'un appareil d'administration de medicament et procede d'assemblage |
| US11904143B2 (en) | 2017-06-08 | 2024-02-20 | Amgen Inc. | Torque driven drug delivery device |
| EP3641857A1 (fr) | 2017-06-22 | 2020-04-29 | Amgen Inc. | Réduction des impacts/chocs d'activation d'un dispositif |
| AU2018290302B2 (en) | 2017-06-23 | 2024-02-29 | Amgen Inc. | Electronic drug delivery device comprising a cap activated by a switch assembly |
| WO2019014014A1 (fr) | 2017-07-14 | 2019-01-17 | Amgen Inc. | Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion |
| US11672733B2 (en) | 2017-07-21 | 2023-06-13 | Amgen Inc. | Gas permeable sealing member for drug container and methods of assembly |
| EP3658206A1 (fr) | 2017-07-25 | 2020-06-03 | Amgen Inc. | Dispositif d'administration de médicament doté d'un système d'accès à un récipient et procédé d'assemblage associé |
| EP3658203B1 (fr) | 2017-07-25 | 2022-08-31 | Amgen Inc. | Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé |
| IL271499B2 (en) | 2017-08-01 | 2024-12-01 | Amgen Inc | Systems and methods for real-time polypeptide sample preparation for mass spectrometry analysis |
| US12025618B2 (en) | 2017-08-01 | 2024-07-02 | Amgen Inc. | Systems and methods for performing a real-time glycan assay of a sample |
| EP3664863A2 (fr) | 2017-08-09 | 2020-06-17 | Amgen Inc. | Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre |
| MA49897A (fr) | 2017-08-18 | 2020-06-24 | Amgen Inc | Injecteur sur-corps avec patch adhésif stérile |
| US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
| ES2939292T3 (es) | 2017-10-04 | 2023-04-20 | Amgen Inc | Adaptador de flujo para dispositivo de administración de fármacos |
| EP4257164A3 (fr) | 2017-10-06 | 2024-01-17 | Amgen Inc. | Dispositif d'administration de médicament comprenant un ensemble de verrouillage et procédé d'assemblage associé |
| EP3694578A1 (fr) | 2017-10-09 | 2020-08-19 | Amgen Inc. | Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé |
| WO2019090086A1 (fr) | 2017-11-03 | 2019-05-09 | Amgen Inc. | Systèmes et approches pour stériliser un dispositif d'administration de médicament |
| WO2019090303A1 (fr) | 2017-11-06 | 2019-05-09 | Amgen Inc. | Ensembles de remplissage-finition et procédés associés |
| EP3706830B1 (fr) | 2017-11-06 | 2024-08-07 | Amgen Inc. | Dispositif d'administration de médicament avec détection de positionnement et de débit |
| JP7247174B2 (ja) | 2017-11-10 | 2023-03-28 | アムジエン・インコーポレーテツド | 薬物送達デバイスのプランジャ |
| JP7370969B2 (ja) | 2017-11-16 | 2023-10-30 | アムジエン・インコーポレーテツド | 薬物送達デバイスの扉ラッチ機構 |
| CN111868531A (zh) | 2018-03-13 | 2020-10-30 | 安进公司 | 用于质谱分析的多肽的依序消化 |
| EP4321870A3 (fr) | 2018-03-13 | 2024-04-03 | Amgen Inc. | Procedes de preparation de polypeptides resistant a la trypsine pour analyse par spectrometrie de masse |
| US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
| US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
| KR102682705B1 (ko) * | 2018-07-04 | 2024-07-05 | 고려대학교 세종산학협력단 | 옥사졸로퀴놀리논 유도체를 유효성분으로 포함하는 우울증 및 스트레스 관련 질환의 예방 또는 치료용 약학 조성물 |
| WO2020023336A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs hybrides d'administration de médicament dotés d'une partie de préhension |
| US12303677B2 (en) | 2018-07-24 | 2025-05-20 | Amgen Inc. | Hybrid drug delivery devices with optional grip portion and related method of preparation |
| WO2020023451A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs d'administration pour l'administration de médicaments |
| WO2020023444A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs d'administration pour l'administration de médicaments |
| US12109389B2 (en) | 2018-07-31 | 2024-10-08 | Amgen Inc. | Fluid path assembly for a drug delivery device |
| WO2020068623A1 (fr) | 2018-09-24 | 2020-04-02 | Amgen Inc. | Systèmes et procédés de dosage interventionnel |
| WO2020068476A1 (fr) | 2018-09-28 | 2020-04-02 | Amgen Inc. | Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament |
| MX2021003492A (es) | 2018-10-02 | 2021-06-18 | Amgen Inc | Sistemas de inyeccion para la administracion de farmacos con transmision de fuerza interna. |
| JP7547325B2 (ja) | 2018-10-05 | 2024-09-09 | アムジエン・インコーポレーテツド | 投薬量インジケータを有する薬物送達デバイス |
| TWI848009B (zh) | 2018-10-15 | 2024-07-11 | 美商安進公司 | 具有阻尼機構之藥物遞送裝置及自動注射器 |
| MX2021002791A (es) | 2018-10-15 | 2021-05-12 | Amgen Inc | Proceso de ensamblaje de plataforma para un dispositivo de administracion de farmacos. |
| EP3873566B1 (fr) | 2018-11-01 | 2024-11-27 | Amgen Inc. | Dispositifs d'administration de médicament avec rétraction partielle de l'organe d'administration de médicament |
| WO2020091981A1 (fr) | 2018-11-01 | 2020-05-07 | Amgen Inc. | Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament |
| TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
| WO2020124008A1 (fr) | 2018-12-14 | 2020-06-18 | Amgen Inc. | Procédé d'adéquation de système destiné à être utilisé avec une détermination de concentration de protéine par pente |
| JP7483731B2 (ja) | 2019-02-14 | 2024-05-15 | アムジエン・インコーポレーテツド | 試料の調製及びその試料のリアルタイムアッセイの実施のためのシステム及び方法 |
| ES2997116T3 (en) | 2019-02-20 | 2025-02-14 | Amgen Inc | Methods of determining protein stability |
| JP7570341B2 (ja) | 2019-03-04 | 2024-10-21 | アムジエン・インコーポレーテツド | 高分子量種のインビボでの可逆性 |
| CA3133459A1 (fr) | 2019-03-27 | 2020-10-01 | Amgen Inc. | Methodes de cartographie de proteines therapeutiques par l'intermediaire d'une technique de resonance magnetique nucleaire bidimensionnelle (2d) a une abondance naturelle pour pro duits biopharmaceutiques formules |
| WO2020219482A1 (fr) | 2019-04-24 | 2020-10-29 | Amgen Inc. | Ensembles et procédés de vérification de stérilisation de seringue |
| CN113853387B (zh) | 2019-06-04 | 2023-04-04 | 江苏恒瑞医药股份有限公司 | 能结合胸腺基质淋巴细胞生成素的抗体及其应用 |
| ES2997211T3 (en) | 2019-06-05 | 2025-02-14 | Amgen Inc | Methods of identifying attributes of therapeutic proteins |
| JP7608439B2 (ja) | 2019-08-23 | 2025-01-06 | アムジエン・インコーポレーテツド | 構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法 |
| MA57519B1 (fr) | 2019-10-28 | 2025-04-30 | Medimmune Limited | Formulations de poudre sèche d'anticorps se liant à la lymphopoïétine stromale thymique (tslp) et leurs procédés d'utilisation |
| CN111171150B (zh) * | 2020-02-05 | 2020-12-08 | 北京智仁美博生物科技有限公司 | 抗人tslp抗体及其用途 |
| AU2021343495A1 (en) | 2020-09-18 | 2023-04-27 | Amgen Inc. | Methods of processing a sample for peptide mapping analysis |
| AU2021376246A1 (en) | 2020-11-05 | 2023-06-08 | Amgen Inc. | Materials and methods for protein processing |
| WO2022246055A1 (fr) | 2021-05-21 | 2022-11-24 | Amgen Inc. | Procédé d'optimisation d'une recette de remplissage pour un récipient de médicament |
| CA3237662A1 (fr) | 2021-11-09 | 2023-05-19 | Amgen Inc. | Production de proteines therapeutiques |
| AU2023375895A1 (en) | 2022-11-07 | 2025-05-15 | Upstream Bio, Inc. | Pharmaceutical compositions comprising anti-human tslp receptor antibodies and methods of using the same |
| WO2024259275A1 (fr) | 2023-06-14 | 2024-12-19 | Bristol-Myers Squibb Company | Quantification en temps quasi réel d'acide sialique de glycoprotéines |
| WO2025101602A1 (fr) | 2023-11-07 | 2025-05-15 | Amgen Inc. | Procédés d'analyse de la teneur en acides aminés d'une protéine thérapeutique |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002506625A (ja) | 1998-03-19 | 2002-03-05 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | サイトカインレセプター共通γ鎖様 |
| ATE419351T1 (de) | 2000-06-28 | 2009-01-15 | Amgen Inc | Thymus-stroma lymphopoietin rezeptor-moleküle und deren verwendung |
| WO2002000723A2 (fr) | 2000-06-28 | 2002-01-03 | Whitehead Institute For Biomedical Research | Molecules de recepteur de lymphopoietine de stroma thymique et utilisations de celles-ci |
| US6890734B2 (en) * | 2000-11-10 | 2005-05-10 | Schering Corporation | Nucleic acids encoding a cytokine receptor complex |
| JP2005516606A (ja) | 2002-02-01 | 2005-06-09 | シェーリング コーポレイション | 哺乳動物のサイトカイン；関連する試薬の使用 |
| PT1651247E (pt) * | 2003-07-18 | 2008-12-15 | Schering Corp | Tratamento e diagnóstico de neoplasmas utilizando linfopoietina de estroma tímico |
| US20050249712A1 (en) | 2004-03-23 | 2005-11-10 | The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services | Methods for use of TSLP and agonists and antagonists thereof |
| CA2577631A1 (fr) * | 2004-08-20 | 2006-03-02 | Amgen Inc. | Procedes et compositions pour le traitement d'inflammation allergique |
| US20060171943A1 (en) | 2005-02-01 | 2006-08-03 | Amgen Inc. | Compositions and methods of treating fibrotic disorders |
| WO2007112146A2 (fr) | 2006-01-13 | 2007-10-04 | Irm Llc | Procédés et compositions permettant de traiter des maladies alleriques |
| CN101986784A (zh) | 2008-02-07 | 2011-03-16 | 先灵公司 | 基因工程tslpr抗体 |
-
2008
- 2008-06-18 EA EA201000006A patent/EA201000006A1/ru unknown
- 2008-06-18 WO PCT/EP2008/057731 patent/WO2008155365A1/fr active Application Filing
- 2008-06-18 KR KR1020107001185A patent/KR20100034015A/ko not_active Ceased
- 2008-06-18 JP JP2010512681A patent/JP2010530233A/ja active Pending
- 2008-06-18 PE PE2008001045A patent/PE20090768A1/es not_active Application Discontinuation
- 2008-06-18 CN CN2008801025460A patent/CN102027012A/zh active Pending
- 2008-06-18 AR ARP080102594A patent/AR067045A1/es not_active Application Discontinuation
- 2008-06-18 BR BRPI0813725-0A2A patent/BRPI0813725A2/pt not_active IP Right Cessation
- 2008-06-18 AU AU2008265128A patent/AU2008265128A1/en not_active Abandoned
- 2008-06-18 CA CA2691157A patent/CA2691157A1/fr not_active Abandoned
- 2008-06-18 EP EP08761179A patent/EP2170957A1/fr not_active Withdrawn
- 2008-06-18 US US12/141,516 patent/US8101182B2/en not_active Expired - Fee Related
- 2008-06-19 CL CL2008001826A patent/CL2008001826A1/es unknown
- 2008-06-19 TW TW097122910A patent/TW200918557A/zh unknown
-
2009
- 2009-12-07 IL IL202573A patent/IL202573A0/en unknown
- 2009-12-08 ZA ZA200908711A patent/ZA200908711B/xx unknown
- 2009-12-09 CR CR11152A patent/CR11152A/es not_active Application Discontinuation
- 2009-12-17 CO CO09144825A patent/CO6251325A2/es not_active Application Discontinuation
- 2009-12-17 TN TNP2009000529A patent/TN2009000529A1/fr unknown
- 2009-12-18 EC EC2009009812A patent/ECSP099812A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200908711B (en) | 2010-08-25 |
| JP2010530233A (ja) | 2010-09-09 |
| CO6251325A2 (es) | 2011-02-21 |
| CN102027012A (zh) | 2011-04-20 |
| EA201000006A1 (ru) | 2010-10-29 |
| BRPI0813725A2 (pt) | 2014-12-30 |
| TW200918557A (en) | 2009-05-01 |
| CA2691157A1 (fr) | 2008-12-24 |
| ECSP099812A (es) | 2010-01-29 |
| EP2170957A1 (fr) | 2010-04-07 |
| CL2008001826A1 (es) | 2009-02-20 |
| AR067045A1 (es) | 2009-09-30 |
| US20090074747A1 (en) | 2009-03-19 |
| PE20090768A1 (es) | 2009-07-09 |
| CR11152A (es) | 2010-01-20 |
| KR20100034015A (ko) | 2010-03-31 |
| US8101182B2 (en) | 2012-01-24 |
| IL202573A0 (en) | 2011-08-01 |
| AU2008265128A1 (en) | 2008-12-24 |
| WO2008155365A1 (fr) | 2008-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2009000529A1 (en) | Methods and compositions for treating allergic diseases | |
| TW200736275A (en) | Methods and compositions for treating allergic diseases | |
| PH12013500564A1 (en) | Anti-cd48 antibodies and uses thereof | |
| PH12012500843A1 (en) | Engineered anti-tslp antibody | |
| MX2010004327A (es) | Anticuerpos anti-vegf completamente humanos y metodos de uso. | |
| PH12015501806B1 (en) | Novel benzopyran kinase modulators | |
| PH12013500355A1 (en) | Engineered anti-tslp antibody | |
| UA108198C2 (uk) | Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування | |
| SG178602A1 (en) | Dual variable domain immunoglobulins and uses thereof | |
| PH12012500815A1 (en) | Dual variable domain immunoglobulins and uses thereof | |
| PH12012500774A1 (en) | Dual variable domain immunoglobulins and uses thereof | |
| MX2012004415A (es) | Inmunoglobulinas de dominio variable doble y usos de las mismas. | |
| MX2012001262A (es) | Inmunoglobulinas de dominio variable doble y usos de las misma. | |
| MX2011011669A (es) | Inmunoglobulinas de dominio variable dual y usos de las misma. | |
| PH12017500864A1 (en) | Anti-notch1 antibodies | |
| MX2010008688A (es) | Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria. | |
| MX338395B (es) | Anticuerpos anti-cxcr5 humanizados, derivados de los mismos y su uso. | |
| MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
| MX2013001267A (es) | ANTICUERPOS A IL-1ß E EIL-18 PARA TRATAMIENTO DE ENFERMEDAD. | |
| MX2014001766A (es) | Anticuerpos de neuregulina y sus usos. | |
| MX357166B (es) | Anticuerpos que se unen a notum pectinacetilesterasa. | |
| PH12015501360A1 (en) | Bmp-6 antibodies | |
| AU2014256372B2 (en) | New compositions for treating CMT and related disorders | |
| MX2010003373A (es) | Moduladores de receptores muscarinicos. | |
| TN2010000463A1 (en) | Compositions and methods for preparing and using same |